Cardiac surgery
Product portfolio
Medtronic cardiac surgery is your strategic partner with an unmatched portfolio of solutions.
Featured cardiac surgery products
VitalFlow™ ECMO system
Designed for simplicity and performance, the VitalFlow™ ECMO system can be configured to accommodate your clinical preferences and hospital protocols.1
Avalus Ultra™ bioprosthesis
Built on the Avalus™ platform that leads in evidence and excels in performance — the Avalus Ultra™ valve facilitates ease at implant2 and is designed to deliver long-term durability with its industry-leading EOAs3,4 and circular design engineered for lifetime patient management.
Penditure™ LAA exclusion system
The Penditure™ device is used for the exclusion of the left atrial appendage in patients undergoing a concomitant cardiac surgery procedure. It is the only LAA clip that can be recaptured, repositioned, and redeployed after deployment during a procedure, putting greater control in the hands of surgeons.5
Surgical valve replacement
Please author Image List Component
Mitral and tricuspid repair
Please author Image List Component
Left atrial appendage management
ECMO
-
Crescent™ RA jugular dual-lumen catheterThe Crescent™ RA catheter is a right atrial-designed dual lumen catheter available in sizes 13, 15, and 19 Fr.
-
Crescent™ jugular dual-lumen catheterThe Crescent™ catheter is a bicaval-designed dual lumen catheter available in sizes 24, 26, 28, 30, and 32 Fr. Used for long-term ECMO.
-
Nautilus™ ECMO oxygenator with Balance™ biosurfaceThe Nautilus™ ECMO oxygenator with Balance™ biosurface, featuring a circular flow-path design, is ready to be incorporated into an ECMO circuit.
-
Nautilus™ Smart ECMO moduleThe Nautilus™ Smart ECMO oxygenator module combines the function of an oxygenator with integrated monitors that display real-time device performance data.
-
Opus™ vascular access kitThe Opus™ vascular access kit offers a convenient solution for the access you need.
-
VitalFlow™ ECMO systemThe VitalFlow™ ECMO system provides control of blood pumping through an extracorporeal circuit during extracorporeal membrane oxygenation (ECMO) procedures.
Surgical ablation
-
Cardioblate™ BP2 irrigated RF surgical ablation deviceThe Cardioblate™ BP2 device uses irrigated bipolar radiofrequency (RF) energy to provide surgeons with a means to ablate cardiac tissue in surgical procedures.
-
Cardioblate™ CryoFlex™ surgical ablation consoleThe Cardioblate™ CryoFlex™ surgical ablation console is the command center for the CryoFlex™ surgical ablation system.
-
Cardioblate™ CryoFlex™ surgical ablation probeCardioblate™ CryoFlex™ probes are used to freeze target tissue and block electrical conduction pathways, creating inflammatory response and cryonecrosis.
-
Cardioblate™ Gemini™-s surgical ablation deviceThe Cardioblate™ Gemini™-s, featuring a malleable neck, is a bipolar irrigated radio-frequency MICS device.
-
Cardioblate™ LP irrigated RF surgical ablation deviceThe Cardioblate™ LP device uses irrigated bipolar radiofrequency (RF) energy to provide surgeons with a means to ablate cardiac tissue.
-
Cardioblate™ surgical ablation penThe Cardioblate™ surgical ablation pen reaches areas of the heart that are difficult to ablate with a bipolar clamp.
-
Valleylab™ FT10 energy platformThe Valleylab™ FT10 energy platform drives our full portfolio of energy-based devices for use in a wide range of procedures.
Extra Corporeal Therapies
-
Bio-Medicus™ NextGen cannulaBio-Medicus™ NextGen arterial and venous cannulae, intended for peripheral placement, are available in sizes appropriate for adult and pediatric patients.
-
autoLog IQ™ autotransfusion systemThe autoLog IQ™ autotransfusion system is an adaptable autotransfusion system that delivers a consistently high-quality blood product automatically.
Medtronic Cardiac Surgery
With every beat, expect more.
Potential complications related to the use of ECMO devices include, but are not limited to, heart, vessel, or lung damage, hypoxia, anemia, irritation, toxic reaction, infection, hemorrhage, liver or kidney failure, stroke, and death. The benefits of extracorporeal support must be weighed against the risk of systemic anticoagulation and must be assessed by the prescribing physician.
Surgical valve replacement risks may include infection, surgical complications, stroke, endocarditis and death.
Possible complications related to the use of Penditure™ LAA exclusion system in combination with open heart surgery are: bleeding, tissue damage, thromboembolism, and pericardial effusion.
- Medtronic design verification data on file. Data may not be indicative of clinical performance.
- Based on internal test report (D00998354), Avalus Ultra™ HFE design validation test report.
- Sabik JF III, Rao V, Dagenais F, et al. 7-year outcomes after surgical aortic valve replacement with a stented bovine pericardial bioprosthesis in over 1100 patients: a prospective multicenter analysis. Eur J Cardiothorac Surg. December 26, 2024;67(1):ezae414.
- Klautz RJM, Rao V, Reardon MJ, et al. Examining the typical hemodynamic performance of nearly 3000 modern surgical aortic bioprostheses. Eur J Cardiothorac Surg. 2024;65(5):ezae122. doi:10.1093/ejcts/ezae122.
- Medtronic design verification data on file. Data may not be indicative of clinical performance.